3-氨基-N-[(4-甲氧基苯基)甲基]-4,6-二甲基噻吩并[2,3-B]吡啶-2-甲酰胺结构式
|
常用名 | 3-氨基-N-[(4-甲氧基苯基)甲基]-4,6-二甲基噻吩并[2,3-B]吡啶-2-甲酰胺 | 英文名 | VU0152100 |
|---|---|---|---|---|
| CAS号 | 409351-28-6 | 分子量 | 341.42700 | |
| 密度 | N/A | 沸点 | N/A | |
| 分子式 | C18H19N3O2S | 熔点 | N/A | |
| MSDS | 中文版 美版 | 闪点 | N/A | |
| 符号 |
GHS06 |
信号词 | Danger |
用途VU0152100是M4 mAChR的变构增强剂,EC50为380 nM。 |
| 中文名 | 3-氨基-N-[(4-甲氧基苯基)甲基]-4,6-二甲基噻吩并[2,3-B]吡啶-2-甲酰胺 |
|---|---|
| 英文名 | 3-amino-N-[(4-methoxyphenyl)methyl]-4,6-dimethylthieno[2,3-b]pyridine-2-carboxamide |
| 英文别名 | 更多 |
| 描述 | VU0152100是M4 mAChR的变构增强剂,EC50为380 nM。 |
|---|---|
| 相关类别 | |
| 参考文献 |
| 分子式 | C18H19N3O2S |
|---|---|
| 分子量 | 341.42700 |
| 精确质量 | 341.12000 |
| PSA | 105.48000 |
| LogP | 4.40600 |
| InChIKey | MDNWGCQSCGNTKH-UHFFFAOYSA-N |
| SMILES | COc1ccc(CNC(=O)c2sc3nc(C)cc(C)c3c2N)cc1 |
| 储存条件 | 2-8℃ |
| 符号 |
GHS06 |
|---|---|
| 信号词 | Danger |
| 危害声明 | H301-H319 |
| 警示性声明 | P301 + P310-P305 + P351 + P338 |
| 危险品运输编码 | UN 2811 6.1 / PGIII |
|
Regulation of synaptic MAPK/ERK phosphorylation in the rat striatum and medial prefrontal cortex by dopamine and muscarinic acetylcholine receptors.
J. Neurosci. Res. 93 , 1592-9, (2015) Dopamine and acetylcholine are two principal transmitters in the striatum and are usually balanced to modulate local neural activity and to maintain striatal homeostasis. This study investigates the r... |
|
|
Investigation of the presence and antinociceptive function of muscarinic acetylcholine receptors in the African naked mole-rat (Heterocephalus glaber).
J. Comp. Physiol. A. Neuroethol. Sens. Neural. Behav. Physiol. 202 , 7-15, (2016) The present study investigated the cholinergic system in the African naked mole-rat (Heterocephalus glaber) with focus on the muscarinic acetylcholine receptor subtypes M1 and M4. The protein sequence... |
|
|
Selective activation of M4 muscarinic acetylcholine receptors reverses MK-801-induced behavioral impairments and enhances associative learning in rodents.
ACS Chem. Neurosci. 5(10) , 920-42, (2014) Positive allosteric modulators (PAMs) of the M4 muscarinic acetylcholine receptor (mAChR) represent a novel approach for the treatment of psychotic symptoms associated with schizophrenia and other neu... |
|
实验名称:Ratio of total drug level in brain to plasma (unknown origin)
来源:ChEMBL
靶标:N/A
External Id:CHEMBL3874735
|
|
实验名称:Primary qHTS assay for small molecule inhibitors of Inositol hexaphosphate kinase 1 (...
来源:NCGC
External Id:IP6K1-p1
|
|
实验名称:Positive allosteric modulation of human muscarinic acetylcholine M4/Gqi5 receptor exp...
来源:ChEMBL
靶标:Muscarinic acetylcholine receptor M4
External Id:CHEMBL5030006
|
|
实验名称:Cytochrome P450 family 3 subfamily A member 4 (CYP3A4) small molecule antagonists: lu...
来源:NCGC
External Id:CYP3A4437
|
|
实验名称:Cytochrome P450 family 2 subfamily D member 6 (CYP2D6) small molecule antagonists: lu...
来源:NCGC
External Id:CYP2D6395
|
|
实验名称:Cytochrome P450 family 2 subfamily C member 9 (CYP2C9) small molecule antagonists: lu...
来源:NCGC
External Id:CYP2C9536
|
| ML108 |
| 3-Amino-N-[(4-methoxyphenyl)methyl]-4,6-dimethyl-thieno[2,3-b]pyridine-2-carboxamide |
| Kinome_1269 |
| VU0152100 |